Concepts (62)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mastocytosis, Systemic | 1 | 2013 | 8 | 0.420 |
Why?
|
| Anemia, Aplastic | 1 | 2013 | 60 | 0.400 |
Why?
|
| CD5 Antigens | 1 | 2009 | 33 | 0.300 |
Why?
|
| Cyclin D1 | 1 | 2009 | 113 | 0.300 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2009 | 31 | 0.300 |
Why?
|
| Flow Cytometry | 2 | 2020 | 791 | 0.210 |
Why?
|
| Biomarkers, Tumor | 2 | 2016 | 1657 | 0.190 |
Why?
|
| Electroporation | 1 | 2019 | 34 | 0.160 |
Why?
|
| Lung Neoplasms | 1 | 2009 | 1535 | 0.150 |
Why?
|
| Lymphoma, Primary Effusion | 1 | 2018 | 4 | 0.150 |
Why?
|
| Lymphadenopathy | 1 | 2018 | 31 | 0.140 |
Why?
|
| Pleural Effusion | 1 | 2018 | 110 | 0.140 |
Why?
|
| Specimen Handling | 1 | 2018 | 149 | 0.140 |
Why?
|
| Osteomyelitis | 1 | 2019 | 213 | 0.130 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2018 | 150 | 0.130 |
Why?
|
| Bone Marrow | 1 | 2018 | 327 | 0.130 |
Why?
|
| Staphylococcus aureus | 1 | 2019 | 479 | 0.120 |
Why?
|
| Burkitt Lymphoma | 1 | 2016 | 141 | 0.110 |
Why?
|
| Staphylococcal Infections | 1 | 2019 | 569 | 0.110 |
Why?
|
| Immunohistochemistry | 3 | 2018 | 1694 | 0.110 |
Why?
|
| Bone Marrow Examination | 1 | 2013 | 14 | 0.110 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2018 | 1342 | 0.110 |
Why?
|
| Antilymphocyte Serum | 1 | 2013 | 42 | 0.100 |
Why?
|
| Mast Cells | 1 | 2013 | 67 | 0.100 |
Why?
|
| Thyroid Neoplasms | 1 | 2016 | 250 | 0.100 |
Why?
|
| Cyclosporine | 1 | 2013 | 126 | 0.100 |
Why?
|
| Prednisone | 1 | 2013 | 253 | 0.100 |
Why?
|
| Quality Improvement | 1 | 2018 | 699 | 0.090 |
Why?
|
| Bone Marrow Cells | 1 | 2013 | 258 | 0.090 |
Why?
|
| Diagnosis, Differential | 2 | 2018 | 1949 | 0.080 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2009 | 32 | 0.080 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2009 | 64 | 0.070 |
Why?
|
| Lymph Nodes | 1 | 2009 | 389 | 0.070 |
Why?
|
| HIV Infections | 1 | 2018 | 2035 | 0.060 |
Why?
|
| Male | 5 | 2019 | 64877 | 0.050 |
Why?
|
| Immunophenotyping | 1 | 2020 | 343 | 0.040 |
Why?
|
| Thoracentesis | 1 | 2018 | 9 | 0.040 |
Why?
|
| Rabbits | 1 | 2019 | 673 | 0.040 |
Why?
|
| Random Allocation | 1 | 2019 | 430 | 0.040 |
Why?
|
| Humans | 6 | 2020 | 131934 | 0.040 |
Why?
|
| Radiography, Thoracic | 1 | 2018 | 153 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2018 | 370 | 0.030 |
Why?
|
| Bronchoscopy | 1 | 2018 | 174 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2009 | 7097 | 0.030 |
Why?
|
| Artifacts | 1 | 2018 | 114 | 0.030 |
Why?
|
| Middle Aged | 2 | 2016 | 28947 | 0.030 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2016 | 119 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2016 | 247 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2016 | 207 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2016 | 768 | 0.030 |
Why?
|
| Biopsy | 1 | 2018 | 1284 | 0.030 |
Why?
|
| Gene Rearrangement | 1 | 2016 | 327 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2016 | 1361 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 2166 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 4682 | 0.020 |
Why?
|
| Adult | 2 | 2018 | 31538 | 0.020 |
Why?
|
| Time Factors | 1 | 2016 | 6440 | 0.020 |
Why?
|
| Young Adult | 1 | 2016 | 9952 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 12995 | 0.010 |
Why?
|
| Animals | 1 | 2019 | 34785 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2016 | 17375 | 0.010 |
Why?
|
| Female | 1 | 2016 | 70592 | 0.000 |
Why?
|